Anees ur Rehman

Dr. Anees ur Rehman

Department of Pharmacy Practice, Bahauddin Zakariya University, Multan, Punjab, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2019 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
ARAnees ur Rehman
Anees ur Rehman
MHMohamed Azmi Ahmad Hassali
Mohamed Azmi Ahmad Hassali
SMSohail Ayaz Muhammad
Sohail Ayaz Muhammad
SHSabariah Noor Harun
Sabariah Noor Harun
SSShahid Shah
Shahid Shah
SASameen Abbas
Sameen Abbas

18 October 2019 in Expert Review of Pharmacoeconomics & Outcomes Research
Verified
Journal Article
Closed access
ARAnees ur Rehman
Anees ur Rehman
MHMohamed Azmi Ahmad Hassali
Mohamed Azmi Ahmad Hassali
SMSohail Ayaz Muhammad
Sohail Ayaz Muhammad
SSShahid Shah
Shahid Shah
SASameen Abbas
Sameen Abbas
ASAhmad Salman
Ahmad Salman
Background: Lack of information about economic burden of COPD, is a major cause of lack of attention to this chronic condition from governments and policymakers. Objective: To find the economic burden of COPD in Asia, USA and Europe, and to identify the key cost driving factors in management of COPD patients. Methodology: Relevant studies assessing the cost of COPD from patient perspective or societal perspective were retrieved by thoroughly searching PUBMED, SCIENCE DIRECT, GOOGLE SCHOLAR, SCOPUS, and SAGE Premier Databases. Results: In USA annual per patient direct medical cost and hospitalization cost were reported as $10367 and $6852 respectively. In Asia annual per patient direct medical cost in Iran, Korea and Singapore was reported as $1544, $3077, and $2335 respectively. Whereas, annual per patient hospitalization cost in Iran, Korea, Singapore, India, China, and Turkey was reported as $865, $1371, $1868, $296, $1477 and $1031 respectively. In Europe annual per patient direct medical cost was reported as $11787, $10552, $8644, $8203, $7760, $3190, $1889, $2162, and $2254 in Norway, Denmark, Germany, Italy, Sweden, Greece, Spain, Belgium, and Serbia respectively. Conclusion: Limiting the disease to early stage and preventing exacerbations may reduce the cost of management of COPD.

19 November 2020 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
Muhammad Fawad RasoolMuhammad Fawad Rasool
Muhammad Fawad Rasool
ARAnees ur Rehman
Anees ur Rehman
Imran ImranImran Imran
Imran Imran
SASameen Abbas
Sameen Abbas
SSShahid Shah
Shahid Shah
KHKhezar Hayat
Khezar Hayat
Introduction: Medication error is unintentional and can be reduced by reducing the risk factors. Patients suffering from chronic diseases are at an increased risk of medication errors. Objective: This work aims to assess the risk factors associated with medication errors among patients suffering from chronic disorders in hospitals of South Punjab, Pakistan. Methodology: Multiple logistic regression analysis was used to assess the impact of different risk factors on the prevalence of medication errors in patients suffering from chronic diseases. Results: A greater risk for the occurrence of medication errors was associated with age ≥60 years (odds ratio, OR = 1.9; 95% CI = 1.3–3.1; p = 0.001), overburdened healthcare system (OR = 2.2; 95% CI = 1.64–3.56; p < 0.000), number of prescribed drugs ≥5 (OR = 1.74; 95% CI = 1.02–2.64; p < 0.000), comorbidities (OR = 2.6; 95% CI = 1.72–3.6; p = 0.003), Charlson comorbidity index (OR = 1.31; 95% CI = 0.49–1.84; p = 0.004), and multiple prescribers to one patient (OR = 1.12; 95% CI = 0.64–1.76; p = 0.001). Conclusion: Older age, overburdened healthcare system, number of prescribed drugs, comorbidities, Charlson comorbidity index, and multiple prescribers to one patient are significant risk factors for the occurrence of medication errors.

6 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Rabia ArshadRabia Arshad
Rabia Arshad
MSMuhammad Farhan Sohail
Muhammad Farhan Sohail
HSHafiz Shoaib Sarwar
Hafiz Shoaib Sarwar
HSHamid Saeed
Hamid Saeed
IAImran Ali
Imran Ali
Gul ShahnazGul Shahnaz
Gul Shahnaz
Post-operative surgical site infections (SSI) present a serious threat and may lead to complications. Currently available dressings for SSI lack mucoadhesion, safety, efficacy and most importantly patient compliance. We aimed to address these concerns by developing a bioactive thiolated chitosan-alginate bandage embedded with zinc oxide nanoparticles (ZnO-NPs) for localized topical treatment of SSI. The FTIR, XRD, DSC and TGA of bandage confirmed the compatibility of ingredients and modifications made. The porosity, swelling index and lysozyme degradation showed good properties for wound healing and biodegradation. Moreover, in-vitro antibacterial activity showed higher bactericidal effect as compared to ZnO-NPs free bandage. In-vivo wound healing in murine model showed significant improved tissue generation and speedy wound healing as compared to positive and negative controls. Over all, thiolated bandage showed potential as an advanced therapeutic agent for treating surgical site infections, meeting the required features of an ideal surgical dressing.

1 July 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MAMuhammad Subhan Arshad
Muhammad Subhan Arshad
IHIltaf Hussain
Iltaf Hussain
TMTahir Mahmood
Tahir Mahmood
KHKhezar Hayat
Khezar Hayat
AMAbdul Majeed
Abdul Majeed
Muhammad Fawad RasoolMuhammad Fawad Rasool
Muhammad Fawad Rasool
The current study aims to assess the beliefs of the general public in Pakistan towards conspiracy theories, acceptance, willingness to pay, and preference for the COVID-19 vaccine. A cross-sectional study was conducted through an online self-administered questionnaire during January 2021. The Chi-square test or Fisher exact test was utilized for statistical data analysis. A total of 2158 respondents completed the questionnaire, among them 1192 (55.2%) were male with 23.87 (SD: ±6.23) years as mean age. The conspiracy beliefs circulating regarding the COVID-19 vaccine were believed by 9.3% to 28.4% of the study participants. Among them, 1040 (48.2%) agreed to vaccinate on its availability while 934 (43.3%) reported the Chinese vaccine as their preference. The conspiracy beliefs of the participants were significantly associated with acceptance of the COVID-19 vaccine. The existence of conspiracy beliefs and low vaccine acceptance among the general population is a serious threat to successful COVID-19 vaccination.

16 November 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
ARAnees ur Rehman
Anees ur Rehman
MKMahnoor Khattak
Mahnoor Khattak
UMUsman Mushtaq
Usman Mushtaq
MLMuhammad Latif
Muhammad Latif
IAImran Ahmad
Imran Ahmad
AHAbdul Haseeb
Abdul Haseeb
Background: The existence of Type 2 Diabetes Mellitus (DM) in tuberculosis (TB) patients is very dangerous for the health of patients. One of the major concerns is the emergence of MDR-TB in such patients. It is suspected that the development of MDR-TB further worsens the treatment outcomes of TB such as treatment failure and thus, causes disease progression.Aim: To investigate the impact of DM on the Emergence of MDR-TB and Treatment Failure in TB-DM comorbid patients.Methodology: The PubMed database was systematically searched until April 03, 2022 (date last searched). Thirty studies met the inclusion criteria and were included in this study after a proper selection process.Results: Tuberculosis-Diabetes Mellitus patients were at higher risk to develop MDR-TB as compared to TB-non-DM patients (HR 0.81, 95% CI: 0.60–0.96, p < 0.001). Heterogeneity observed among included studies was moderate (I2 = 38%). No significant change was observed in the results after sub-group analysis by study design (HR 0.81, 95% CI: 0.61–0.96, p < 0.000). In the case of treatment failure, TB-DM patients were at higher risk to experience treatment failure rates as compared to TB-non-DM patients (HR 0.46, 95% CI: 0.27–0.67, p < 0.001).Conclusion: The results showed that DM had a significant impact on the emergence of MDR-TB in TB-diabetes comorbid patients as compared to TB-non-DM patients. DM enhanced the risk of TB treatment failure rates in TB-diabetes patients as compared to TB-non-DM patients. Our study highlights the need for earlier screening of MDR-TB, thorough MDR-TB monitoring, and designing proper and effective treatment strategies to prevent disease progression.